Roger Franklin

Direktor/Vorstandsmitglied bei ABLIVA AB

47 Jahre

Health Technology

Finance

Consumer Services

Profil

Roger Franklin is currently the Director at Abliva AB. He also holds positions as Director at Gesynta Pharma AB, TargED Biopharmaceuticals BV, Crosslanes Holding AB, and Complement Therapeutics GmbH.
Additionally, he is the Deputy Director at HVentures Capital i AB, HVentures Capital II AB, HVentures AB, and Partner at Hadean Ventures AS.
Previously, he worked as Deputy Director at SAGA Diagnostics AB and Analyst at Panmure Liberum Capital Ltd. from 2010 to 2018.
Dr. Franklin obtained an undergraduate degree from the University of Oxford and a doctorate from the University of Cambridge.

Aktive Positionen von Roger Franklin

Unternehmen	Position	Beginn
ABLIVA AB	Direktor/Vorstandsmitglied	20.05.2020
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments.	Private Equity Investor	-
Gesynta Pharma AB Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions	Direktor/Vorstandsmitglied	-
Crosslanes Holding AB	Direktor/Vorstandsmitglied	-
TargED Biopharmaceuticals BV TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis	Direktor/Vorstandsmitglied	-
HVentures Capital i AB HVentures Capital i AB Investment ManagersFinance Provides private equity fund services	Corporate Officer/Principal	-
HVentures Capital II AB HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund	Corporate Officer/Principal	-

Alle aktiven Positionen von Roger Franklin

Ehemalige bekannte Positionen von Roger Franklin

Unternehmen	Position	Ende
Liberum Capital Ltd. Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31.10.2018
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Roger Franklin im Detail an

Ausbildung von Roger Franklin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Roger Franklin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Abliva AB Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases	Health Technology
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Liberum Capital Ltd. Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
SAGA Diagnostics AB SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance	Health Technology
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments.	Finance
Gesynta Pharma AB Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions	Health Technology
HVentures Capital i AB HVentures Capital i AB Investment ManagersFinance Provides private equity fund services	Finance
TargED Biopharmaceuticals BV TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis	Health Technology
HVentures Capital II AB HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund	Finance
Crosslanes Holding AB